Citations

Showing 10 of 108119 citations.

Exostosin 1/Exostosin 2–Associated Membranous Nephropathy
Sethi, Sanjeev , Dêbiec, Hanna , Charlesworth, M. Cristine , Gross, LouAnn, Ravindran, Aishwarya , Hummel, Amber M., Fervenza, Fernando C. , Fervenza, Fernando C , Ravindran, Aishwarya , Madden, Benjamin , Charlesworth, M. Cristine , Specks, Ulrich , Ronco, Pierre Marie

Mayo Clinic

Journal of the American Society of Nephrology | May 7, 2019 | Volume: 30 | Issue: 6 | Pages: 1123-1136

10.1681/asn.2018080852 | PMID 31061139 Get It

Significance Statement In approximately 70%–80% of cases of primary membranous nephropathy (MN), phospholipase A2 receptor (PLA2R)/Thrombospondin Type-1 Domain–Containing 7A (THSD7A) and anti-PLA2R/THSD7A antibodies form immune complexes along the glomerular basement membrane (GBM) that characterize the condition. In other cases of primary MN and all secondary MN, the target antigen is unknown. Using proteomics and immunohistochemistry, the authors detected two proteins, exostosin 1 (EXT1) and exostosin 2 (EXT2), in the GBM of PLA2R-negative MN. EXT1 and EXT2 were absent in all cases of PLA2R-associated MN and controls. Clinical and biopsy findings showed features of autoimmune disease, including membranous lupus nephritis, in 81% of the 26 EXT1/EXT2-associated MN cases the authors identified. These findings suggest that EXT1/EXT2-associated MN represents a distinct subtype of MN, most commonly associated with autoimmune diseases (secondary MN). Background In membranous nephropathy (MN), which is characterized by deposition of immune complexes along the glomerular basement membrane (GBM), phospholipase A2 receptor (PLA2R) and thrombospondin type 1 domain–containing 7A are target antigens in approximately 70% and 1%–5% of cases of primary MN, respectively. In other cases of primary MN and in secondary MN, the target antigens are unknown. Methods We studied 224 cases of biopsy-proven PLA2R-negative MN and 102 controls (including 47 cases of PLA2R-associated MN) in pilot and discovery cohorts. We also evaluated 48 cases of PLA2R-negative presumed primary MN and lupus MN in a validation cohort. We used laser microdissection and mass spectrometry to identify new antigens, which were localized by immunohistochemistry. Results Mass spectrometry detected exostosin 1 (EXT1) and exostosin 2 (EXT2) in 21 cases of PLA2R-negative MN, but not in PLA2R-associated MN and control cases. Immunohistochemistry staining revealed bright granular GBM staining for EXT1 and EXT2. Clinical and biopsy findings showed features of autoimmune disease, including lupus, in 80.7% of the 26 EXT1/EXT2-associated MN cases we identified. In the validation cohort, we confirmed that EXT1/EXT2 staining was detected in pure class 5 lupus nephritis (eight of 18 patients) and in presumed primary MN associated with signs of autoimmunity (three of 16 patients); only one of the 14 cases of mixed class 5 and 3/4 lupus nephritis was positive for EXT1/EXT2. Tests in seven patients with EXT1/EXT2-associated MN found no circulating anti-exostosin antibodies. Conclusions A subset of MN is associated with accumulation of EXT1 and EXT2 in the GBM. Autoimmune disease is common in this group of patients.
Radiologist’s Primer on Imaging of Common Hereditary Cancer Syndromes
Tiwari, Ruchi , Singh, Achint K. , Somwaru, Alexander S. , Menias, Christine O. , Katabathina, Venkata S. , Prasad, Srinivasa R, Prasad, Srinivasa R.

Mayo Clinic

RadioGraphics | May 7, 2019 | Volume: 39 | Issue: 3 | Pages: 759-778

10.1148/rg.2019180171 | PMID 31059391 Get It

Photon-counting Detector CT: System Design and Clinical Applications of an Emerging Technology
Leng, Shuai , Bruesewitz, Michael R. , Tao, Shengzhen , Halaweish, Ahmed F., Fletcher, Joel G. , McCollough, Cynthia H. , Bruesewitz, Michael, Fletcher, Joel G , McCollough, Cynthia H , Leng, Shuai , Rajendran, Kishore , Campeau, Norbert G.

Mayo Clinic

RadioGraphics | May 7, 2019 | Volume: 39 | Issue: 3 | Pages: 729-743

10.1148/rg.2019180115 | PMID 31059394 Get It

Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial
Gangat, Naseema , Marinaccio, Christian , Swords, Ronan , Watts, Justin M. , Rademaker, Alfred , Fought, Angela J. , Frankfurt, Olga, Altman, Jessica K. , Wen, Qiang , Farnoud, Noushin , Famulare, Christopher , Patel, Akshar, Vallapureddy, Rangit, Barath, Stephanie, Graf, Amy, Handlogten, Amy, Zblewski, Darci, Patnaik, Mrinal M. , Al‐Kali, Aref , Dinh, Yvonne, Prahl, Kristen Englund, Patel, Shradha, Nobrega, Juan Carlos , Tejera, Dalissa, Thomassen, Amber , Gao, Juehua , Rampal, Raajit K. , Tefferi, Ayalew , Stein, Brady L. , Crispino, John D. , Vallapureddy, Rangit R, Rampal, Raajit K , Giles, Francis Joseph , Crispino, John D , Gurbuxani, Sandeep K. , Wen, Qiang Jeremy, TAPIA-CONYER, ROBERTO C. , Ji, Peng Cheng

Mayo Clinic

Clinical Cancer Research | May 7, 2019 | Volume: 25 | Issue: 16 | Pages: 4898-4906

10.1158/1078-0432.ccr-19-1005 | PMID 31061068 Get It

Abstract Purpose: Myelofibrosis is characterized by bone marrow fibrosis, atypical megakaryocytes, splenomegaly, constitutional symptoms, thrombotic and hemorrhagic complications, and a risk of evolution to acute leukemia. The JAK kinase inhibitor ruxolitinib provides therapeutic benefit, but the effects are limited. The purpose of this study was to determine whether targeting AURKA, which has been shown to increase maturation of atypical megakaryocytes, has potential benefit for patients with myelofibrosis. Patients and Methods: Twenty-four patients with myelofibrosis were enrolled in a phase I study at three centers. The objective of the study was to evaluate the safety and preliminary efficacy of alisertib. Correlative studies involved assessment of the effect of alisertib on the megakaryocyte lineage, allele burden, and fibrosis. Results: In addition to being well tolerated, alisertib reduced splenomegaly and symptom burden in 29% and 32% of patients, respectively, despite not consistently reducing the degree of inflammatory cytokines. Moreover, alisertib normalized megakaryocytes and reduced fibrosis in 5 of 7 patients for whom sequential marrows were available. Alisertib also decreased the mutant allele burden in a subset of patients. Conclusions: Given the limitations of ruxolitinib, novel therapies are needed for myelofibrosis. In this study, alisertib provided clinical benefit and exhibited the expected on-target effect on the megakaryocyte lineage, resulting in normalization of these cells and reduced fibrosis in the majority of patients for which sequential marrows were available. Thus, AURKA inhibition should be further developed as a therapeutic option in myelofibrosis. See related commentary by Piszczatowski and Steidl, p. 4868
Ultrasound Assessment of Weight‐Bearing and Non–Weight‐Bearing Meniscal Extrusion: A Reliability Study
Reisner, Jacob H. , Franco, John , Johnson, Adam C. , Sellon, Jacob L. , Finnoff, Jonathan T. , Franco, John M, Finnoff, Jonathan T , Hollman, John H.

Mayo Clinic

PM&R | May 7, 2019 | Volume: 12 | Issue: 1 | Pages: 26-35

10.1002/pmrj.12183 | PMID 31062914 Get It

BackgroundUltrasound has become a useful instrument in evaluating musculoskeletal pathology. Recent studies suggest that ultrasound imaging of weight‐bearing menisci may enhance the assessment of knee pathology, such as osteoarthritis (OA) and meniscal injuries.ObjectiveThe primary aim of this study was to determine the intrarater and interrater reliability of ultrasound measurements of medial meniscal extrusion (MME) after a brief training session.DesignProspective reliability study.SettingPhysical medicine and rehabilitation (PM&R) department within a tertiary care institution.ParticipantsForty‐five participants (29 female, 16 male) were recruited to serve as models, 24 of whom had healthy knees and 21 of whom had radiographically confirmed medial compartment knee OA. Three physician sonographers (1 = experienced, 1 = sports medicine fellow, 1 = post‐graduate year [PGY]‐4 PM&R resident) were recruited to serve as operators.Methods or InterventionsOperators received a brief training session on identifying and measuring MME. All operators measured bilateral MME in each model in the standing and supine positions on two separate days. Operators were blinded to all measurements.Main Outcome MeasurementsPrimary outcomes were inter‐ and intrarater intraclass correlation coefficients (ICCs) of MME measurements among operators with different levels of ultrasound experience.ResultsSupine MME intrarater reliability ICCs were 0.927, 0.885, and 0.780 for the experienced physician, sports medicine fellow, and PGY‐4 operators, respectively. Standing MME intrarater reliability ICCs were 0.941, 0.902, and 0.824 for the experienced physician, sports medicine fellow, and PGY‐4 operators, respectively. Interrater reliability ICCs were 0.896 and 0.842 for supine and standing measurements, respectively. There was a statistically significant increase in intrarater reliability with experience between the PGY‐4 resident and experienced physician operators.ConclusionsOperators with different levels of ultrasound experience demonstrated good MME measurement intra‐ and interrater reliabilities in both supine and standing positions.
Balloon‐occluded retrograde transvenous obliteration versus endoscopic injection for gastric variceal bleeding: a systematic review and meta‐analysis
Ahmad, Dina, Hamdeh, Shadi , Altayar, Osama , Devineni, Harish, Esmadi, Mohammad , Olivera‐Martinez, Marco , Murad, M. Hassan , Altayar, Osama

Mayo Clinic

GastroHep | May 7, 2019 | Volume: 1 | Issue: 3 | Pages: 138-145

10.1002/ygh2.340 Get It

Clinical Strategies to Prevent Acute Respiratory Distress Syndrome
Odeyemi, Yewande , Gong, Michelle N. , Gajić, Ognjen, Odeyemi, Yewande E, Herasevich, Svetlana , Gajic, Ognjen O, Gajic, Ognjen

Mayo Clinic

Seminars in Respiratory and Critical Care Medicine | May 6, 2019 | Volume: 40 | Issue: 01 | Pages: 129-136

10.1055/s-0039-1683997 | PMID 31060094 Get It

AbstractAcute respiratory distress syndrome (ARDS) remains an important clinical entity in the intensive care unit with a significant impact on morbidity and mortality. Effective therapeutic interventions are limited; thus current research focus has shifted from treatment to the prevention of this pulmonary syndrome. In recent decades, a decrease in the incidence of ARDS has been observed and this reduction is largely due to preventive strategies including safe lung ventilation practices, avoidance of iatrogenic exposures, and improvement in care of predisposing conditions such as sepsis and pneumonia. Early identification of at-risk patients, prompt treatment of predisposing conditions, and adoption of evidence-based best practice including restrictive transfusion strategies, conservative fluid management, avoidance of large tidal volume ventilation, and aspiration precaution practices are key preventive strategies with demonstrated benefits. There are currently no effective pharmacological preventive strategies for ARDS.
Reply to “Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas”
Lassen–Ramshad, Yasmin , Özyar, Enis , Alanyalı, Senem , Poortmans, Philip , Houtte, Paul Van , Sohawon, Schoeb, Esassolak, Mustafa , Krengli, Marco , Miller, Robert C. , Demiroz, C. , Akyürek, Serap , Aggerholm‐Pedersen, Ninna , Villà, S. , Thariat, Juliette

Mayo Clinic

Head & Neck | May 6, 2019 | Volume: 41 | Issue: 8 | Pages: 2837-2838

10.1002/hed.25800 | PMID 31058391 Get It

Endoscopic augmentation of gastroesophageal junction using a full-thickness endoscopic suturing device
Han, Jimin , Chin, Matthew, Fortinsky, Kyle J. , Sharaiha, Reem Z. , Gostout, Christopher J., Chang, Kenneth J.

Mayo Clinic

Endoscopy International Open | May 6, 2019 | Volume: 06 | Issue: 09 | Pages: E1120-E1125

10.1055/a-0603-3693 | PMID 30211301 Get It

Abstract Background and study aims This preliminary study was conducted to determine the feasibility and safety of endoscopic augmentation of the gastroesophageal junction (GEJ) using the Apollo OverStitch endoscopic suturing system in patients with gastroesophageal reflux disease (GERD) symptoms. Patients and methods Endoscopic augmentation of GEJ was performed on 10 consecutive patients and the data were analyzed retrospectively. Using a double-channel gastroscope affixed to the endoscopic suturing platform, interrupted sutures were placed on the gastric side of the GEJ in 2 layers in order to create a narrowed and elongated GEJ. Results Technical success was achieved in all patients, including those with a history of previous antireflux procedures (n = 7) and those with a hiatal hernia (n = 6). The median follow-up duration was 5 mo (range: 2 – 12). The median pre-procedure GERD-Health Related Quality of Life Questionnaire improved from 20 (range: 11 – 45) to a post-procedure score of 6 (range: 3 – 25) (P = 0.001). The median duration of GERD symptom improvement after the procedure was 1 mo (range: 0.5 – 4). Adverse events were limited to 1 patient who developed nausea and vomiting, which was self-limited. Conclusions The use of a novel endoscopic suturing technique for the treatment of GERD is feasible and safe. The procedure resulted in short-term GERD symptom improvement. Further prospective studies using refined techniques are currently underway to improve durability and to prove efficacy.
Baseline significant tricuspid regurgitation is associated with higher mortality in transcatheter aortic valve replacement: systemic review and meta-analysis
Kittipibul, Veraprapas , Tokavanich, Nithi , Rattanawong, Pattara , Angsubhakorn, Natthapon , Gillaspie, Erin A. , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Rattanawong, Pattara , Prasitlumkum, Narut , Kewcharoen, Jakrin , Mao, Michael A.

Mayo Clinic

Journal of Cardiovascular Medicine | May 6, 2019 | Volume: 20 | Issue: 7 | Pages: 477-486

10.2459/jcm.0000000000000807 | PMID 31593560 Get It

Introduction Significant tricuspid regurgitation is a well recognized indicator of right ventricular dysfunction. Recent studies have shown that significant tricuspid regurgitation is potentially associated with increased mortality in patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR). However, data remained sparse and inconclusive. Thus, we performed a systematic review and meta-analysis of the literature to assess the association between significant tricuspid regurgitation and mortality in post TAVR patients. Hypothesis Significant tricuspid regurgitation is predictive for higher mortality in patients undergoing TAVR. Methods We comprehensively searched the databases of MEDLINE and EMBASE from inception to October 2018. Included studies were published observational studies that reported multivariate analysis of the effects of significant tricuspid regurgitation on all-cause mortality among patients undergoing TAVR. Data from each study were combined utilizing the random-effects, generic inverse variance method of DerSimonian and Laird to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Results Nine cohort studies from August 2011 to May 2018 consisting of 27 614 patients with severe aortic stenosis undergoing TAVR (6255 with and 21 359 without significant tricuspid regurgitation) were included in this meta-analysis. The presence of significant tricuspid regurgitation was associated with higher all-cause mortality (pooled OR = 2.26, 95% CI: 1.45–3.52, P < 0.001). We found that all-cause mortality remained statistically substantial in all subgroups (30-day all-cause mortality: OR = 2.05, 95% CI: 1.20–3.49, P = 0.009; midterm all-cause mortality: OR = 9.67, 95% CI: 2.44–38.31, P = 0.001; and long-term all-cause mortality: OR = 1.48, 95% CI: 1.19–1.85, P < 0.001). Funnel plots and Egger's regression asymmetry test were performed and showed no publication bias. Conclusion Significant tricuspid regurgitation increased risk of mortality by up to two-fold among patients with severe aortic stenosis undergoing TAVR. Our study suggests that significant tricuspid regurgitation should be considered a component of risk stratification tools.